Susan Moran

Insider Reports History

Location
1232 Richardson Ave, Los Altos, CA
Signature
/s/ Barbara Bispham, as attorney-in-fact for Susan Moran
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan Moran:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BioAtla, Inc. Director Common Stock 52.3K $22.5K $0.43 Jun 18, 2025 Direct
RayzeBio, Inc. CHIEF MEDICAL OFFICER Common Stock 0 $0 $62.50 Feb 26, 2024 Direct
Tyra Biosciences, Inc. Director Stock Option (Right to Buy) 22.2K May 29, 2025 Direct
CRESCENT BIOPHARMA, INC. Director Stock Option (Right to Buy) 9.02K Jun 23, 2025 Direct
RayzeBio, Inc. CHIEF MEDICAL OFFICER Employee Stock Option (right to buy) 0 Feb 26, 2024 Direct

Insider Reports Filed by Susan Moran

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CBIO GLYCOMIMETICS INC Jun 23, 2025 1 $0 4 Jun 23, 2025 Director
BCAB BioAtla, Inc. Jun 18, 2025 1 $0 4 Jun 18, 2025 Director
CBIO GLYCOMIMETICS INC Jun 13, 2025 0 $0 3 Jun 23, 2025 Director
TYRA Tyra Biosciences, Inc. May 29, 2025 1 $0 4 Jun 2, 2025 Director
BCAB BioAtla, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
TYRA Tyra Biosciences, Inc. May 7, 2024 1 $0 4 May 9, 2024 Director
TYRA Tyra Biosciences, Inc. May 7, 2024 0 $0 3 May 9, 2024 Director
RYZB RayzeBio, Inc. Feb 26, 2024 5 -$20.2M 4 Feb 27, 2024 CHIEF MEDICAL OFFICER
RYZB RayzeBio, Inc. Jan 22, 2024 2 $100K 4 Feb 6, 2024 CHIEF MEDICAL OFFICER
RYZB RayzeBio, Inc. Nov 17, 2023 1 $0 4 Nov 17, 2023 Chief Medical Officer
RYZB RayzeBio, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 Chief Medical Officer
BCAB BioAtla, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
BCAB BioAtla, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
BCAB BioAtla, Inc. Jun 15, 2021 1 $0 4 Jun 16, 2021 Director